Social media listening has been increasingly acknowledged as a tool with applications in many stages of the drug development process. These applications were created to meet the need for patient-centric therapies that are fit-for-purpose and meaningful to patients. Such applications, however, require the leverage of new quantitative approaches and analytical methods that draw from developments in artificial intelligence and real-world data (RWD) analysis. Here, we review the state-of-the-art in quantitative social media listening (QSML) methods applied to drug discovery from the perspective of the pharmaceutical industry.
Keywords: Artificial intelligence; Natural language processing; Patient-centric drug discovery; Real-world data; Social media analysis; Social media listening.
Copyright © 2022 Elsevier Ltd. All rights reserved.